Effects of Isolated Rooms on the Prevalence of Hospital Acquired Pneumonia in a Respiratory ICU
This study has been completed.
Sponsor:
Eskisehir Osmangazi University
Information provided by:
Eskisehir Osmangazi University
ClinicalTrials.gov Identifier:
NCT01250691
First received: November 30, 2010
Last updated: NA
Last verified: January 2004
History: No changes posted
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | November 30, 2010 | ||||
| Last Updated Date | November 30, 2010 | ||||
| Start Date ICMJE | January 2004 | ||||
| Primary Completion Date | July 2008 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE | Not Provided | ||||
| Original Primary Outcome Measures ICMJE | Not Provided | ||||
| Change History | No Changes Posted | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Effects of Isolated Rooms on the Prevalence of Hospital Acquired Pneumonia in a Respiratory ICU | ||||
| Official Title ICMJE | Epidemiologic Study of Hospital Acquired Pneumonia in a Respiratory ICU | ||||
| Brief Summary | This study will carry out in the ICU. Objectives of the study are to determine the frequency of HAP and the effect of isolated rooms on the frequency of pneumonia in the ICU. |
||||
| Detailed Description | In the present study, it was aimed to determine the incidence, causative agents, antimicrobial resistance, and risk factors for lower respiratory tract infections in patients followed in the ICU for the last 4 years. The effect of reconfiguration from a ward-type ICU consisting one large room to an ICU with isolated rooms with two beds on the incidence of HAP was also determined. |
||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Cohort Time Perspective: Cross-Sectional |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Not Provided | ||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | All of the patients who had been admitted to the ICU during this period were included in the study |
||||
| Condition ICMJE |
|
||||
| Intervention ICMJE | Other: ward-type ICU
frequency of hospital acquired pneumonia in the ICU
Other Name: frequency of hospital acquired pneumonia in the ICU |
||||
| Study Group/Cohort (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 532 | ||||
| Completion Date | August 2010 | ||||
| Primary Completion Date | July 2008 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | Turkey | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01250691 | ||||
| Other Study ID Numbers ICMJE | HAP-OU-isolation | ||||
| Has Data Monitoring Committee | Yes | ||||
| Responsible Party | Eskisehir Osmangazi University, Department of Chest Diseases, Intensive Care Unit, Eskisehir Osmangazi University | ||||
| Study Sponsor ICMJE | Eskisehir Osmangazi University | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Eskisehir Osmangazi University | ||||
| Verification Date | January 2004 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||